Lava Therapeutics

Creates and develops next generation γδ T cell engaging bispecific antibodies for the treatment of cancer. Learn more

Launch date

2016

Employees

Market cap

Enterprise valuation

(AUD56m) (Public information from Sep 2024)

Company register number 65335740

Utrecht Utrecht (HQ), Amsterdam North Holland (founding location)

https://lavatherapeutics.com/

https://twitter.com/lavatx https://www.linkedin.com/company/lavatherapeutics/

View job openings

Authorizing premium user...